Sarepta Therapeutics Inc (NASDAQ:SRPT)

79.99
Delayed Data
As of Apr 20
 +1.44 / +1.83%
Today’s Change
28.82
Today|||52-Week Range
84.37
+43.76%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Revenue and IncomeNet Revenues16.3M35.0M46.0M57.3M
 
 
 
 
 
Cost of Goods Sold252.0K534.0K1.3M1.6M
 
 
 
 
 
Depreciation And Amortization1.6M1.8M2.6M2.1M
 
 
 
 
 
 
Operating ExpensesGross Income14.5M32.7M42.1M53.5M
 
 
 
 
 
General Expenses53.5M90.7M62.4M76.4M
 
 
 
 
 
Research And Development29.0M58.8M34.2M44.4M
 
 
 
 
 
Total Operating Expenses55.4M93.0M66.3M80.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-39.0M-58.0M-20.3M-22.9M
 
 
 
 
 
Extraordinary Credit125.0M0.000.000.00
 
 
Extraordinary Charge-236.0K-5.4M-25.6M-247.0K
 
 
 
 
 
Interest Expense On Debt------2.7M
 
 
Other Expenses335.0K184.0K184.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income86.1M-63.2M-45.7M-25.8M
 
 
 
 
 
Income Taxes-2.0M-109.0K-2.0M-1.8M
 
 
 
 
 
Net Income84.1M-63.0M-47.7M-24.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS54.9M55.0M61.5M64.3M
 
 
 
 
 
Shares To Calculate EPS Diluted56.0M55.0M61.5M64.3M
 
 
 
 
 
 
Earnings Per ShareEPS$1.50-$1.15-$0.78-$0.37
 
 
 
 
 
EPS Diluted$1.50-$1.15-$0.78-$0.37